() promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma.
Oncoimmunology
View this publicationOncoimmunology
View this publicationImmunological investigations
View this publicationStatistics in medicine
View this publicationReviews in cardiovascular medicine
View this publicationThe Lancet. Haematology
View this publicationJournal of functional biomaterials
View this publicationPublication categories: Top publication
Nucleic acids research
View this publicationBiology direct
View this publicationRadiologie (Heidelberg, Germany)
View this publicationScientific reports
View this publication